MedTrace Logo

Evaluation of New Biomarkers in Stage 3 and 4 Endometriosis

NCT05312528 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 79

Last updated 2022-04-05

No results posted yet for this study

Summary

The diagnostic value of Annexin V, sVCAM-1, sICAM-1, vascular endothelial growth factor and Proinflammatory cytokines (TNF-a and interleukin-6) in ovarian endometriosis and deep infiltrating endometriosis, their levels in organ-specific involvement, their relationship with symptoms, and the changes of these markers in the postoperative period will be evaluated.

Conditions

  • Endometriosis

Interventions

PROCEDURE

endometriosis surgery

Laparoscopy was performed in the follicular phase of the woman's menstrual cycle and all recognizable endometriotic lesions were treated by bipolar coagulation, resection of endometriotic nodules and ovarian cystectomy.

PROCEDURE

other benign condition surgeries

ovarian cystectomy, bilateral tubal ligation, myomectomy etc.

Sponsors & Collaborators

  • Bagcilar Training and Research Hospital

    lead OTHER_GOV

Principal Investigators

  • Evrim Ebru Kovalak, MD · Bagcilar Training and Research Hospital

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-02-01
Primary Completion
2019-02-01
Completion
2019-03-01

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05312528 on ClinicalTrials.gov